Proactive Investors
21 Oct 2026, 08:35 UTC · 2h ago
Halfords shares fall 9% despite strong first-half sales as H2 investment weighs on outlook
Impact · against what's priced in
Halfords' shares fell as the market focused on increased H2 spending rather than H1 sales growth, suggesting a shift in focus toward margin pressure. Ondine Biomedical provides a positive update on fundraising and clinical results, though these lack established pricing benchmarks.
- OBI+0.40
No priced-in read yet
- In context
The company reported positive top-line Phase 3 results and successfully completed a £10 million fundraising round.
Read from the article alone
